Literature DB >> 20484669

MAP kinase-activated protein kinases 2 and 3 are required for influenza A virus propagation and act via inhibition of PKR.

Christina Luig1, Katharina Köther, Sabine Eva Dudek, Matthias Gaestel, John Hiscott, Viktor Wixler, Stephan Ludwig.   

Abstract

Influenza viruses have to overcome the type I interferon induced antiviral response to successfully propagate in target cells. A major antiviral factor induced by interferons is the protein kinase R (PKR) that is further activated by dsRNA and phosphorylates the eukaryotic initiation factor 2 (eIF2α). This results in inhibition of protein translation thereby limiting viral replication. Here we describe a novel mechanism by which influenza A viruses escape the antiviral action of PKR. We demonstrate that the mitogen-activated protein kinase-activated protein kinases (MAPKAPKs) MK2 and MK3 are activated on virus infection and, in their active form, directly interact with the repressor of the inhibitor of PKR p88(rIPK). This leads to recruitment of a tetrameric protein complex consisting of p88(rIPK), the inhibitor of PKR p58(IPK) and PKR itself, and finally results in inhibition of the kinase. The importance of MKs for influenza virus propagation was further underscored by demonstrating reduced viral progeny in cells genetically deficient in MK2 or MK3 genes as well as in highly proliferating tumor cells, in which expression of MKs was diminished by specific small interfering RNA. Accordingly, knockdown of MKs resulted in enhanced phosphorylation of PKR and its substrate eIF2α.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20484669     DOI: 10.1096/fj.10-158766

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  14 in total

1.  Cardiac glycosides decrease influenza virus replication by inhibiting cell protein translational machinery.

Authors:  Luciano Amarelle; Jeremy Katzen; Masahiko Shigemura; Lynn C Welch; Héctor Cajigas; Christin Peteranderl; Diego Celli; Susanne Herold; Emilia Lecuona; Jacob I Sznajder
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-03-20       Impact factor: 5.464

2.  Virus infection rapidly activates the P58(IPK) pathway, delaying peak kinase activation to enhance viral replication.

Authors:  Alan G Goodman; Bertrand C W Tanner; Stewart T Chang; Mariano Esteban; Michael G Katze
Journal:  Virology       Date:  2011-05-25       Impact factor: 3.616

3.  Influenza A virus directly modulates mouse eosinophil responses.

Authors:  Kim S LeMessurier; Robert Rooney; Hazem E Ghoneim; Baoming Liu; Kui Li; Heather S Smallwood; Amali E Samarasinghe
Journal:  J Leukoc Biol       Date:  2020-05-09       Impact factor: 4.962

4.  MAPKAP kinase 3 suppresses Ifng gene expression and attenuates NK cell cytotoxicity and Th1 CD4 T-cell development upon influenza A virus infection.

Authors:  Katharina Köther; Carolin Nordhoff; Dörthe Masemann; Georg Varga; Jay H Bream; Matthias Gaestel; Viktor Wixler; Stephan Ludwig
Journal:  FASEB J       Date:  2014-06-16       Impact factor: 5.191

5.  Modulation of mitogen-activated protein kinase-activated protein kinase 3 by hepatitis C virus core protein.

Authors:  Huong T T Ngo; Long V Pham; Jong-Wook Kim; Yun-Sook Lim; Soon B Hwang
Journal:  J Virol       Date:  2013-03-13       Impact factor: 5.103

6.  Tumour promoting and suppressing roles of the atypical MAP kinase signalling pathway ERK3/4-MK5.

Authors:  Sergiy Kostenko; Gianina Dumitriu; Ugo Moens
Journal:  J Mol Signal       Date:  2012-07-16

7.  Evidence for a Novel Mechanism of Influenza Virus-Induced Type I Interferon Expression by a Defective RNA-Encoded Protein.

Authors:  Yvonne Boergeling; Timofey S Rozhdestvensky; Mirco Schmolke; Patricia Resa-Infante; Thomas Robeck; Gerrit Randau; Thorsten Wolff; Gülsah Gabriel; Jürgen Brosius; Stephan Ludwig
Journal:  PLoS Pathog       Date:  2015-05-29       Impact factor: 6.823

Review 8.  Oncogenes: The Passport for Viral Oncolysis Through PKR Inhibition.

Authors:  Janaina Fernandes
Journal:  Biomark Cancer       Date:  2016-07-28

9.  Broad-Spectrum Inhibition of Respiratory Virus Infection by MicroRNA Mimics Targeting p38 MAPK Signaling.

Authors:  Jana L McCaskill; Sarah Ressel; Andreas Alber; Jane Redford; Ultan F Power; Jürgen Schwarze; Bernadette M Dutia; Amy H Buck
Journal:  Mol Ther Nucleic Acids       Date:  2017-04-06

10.  Saikosaponin A inhibits influenza A virus replication and lung immunopathology.

Authors:  Jianxin Chen; Mubing Duan; Yaqin Zhao; Fangfang Ling; Kun Xiao; Qian Li; Bin Li; Chunni Lu; Wenbao Qi; Zhenling Zeng; Ming Liao; Yahong Liu; Weisan Chen
Journal:  Oncotarget       Date:  2015-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.